Clinical Trial Detail

NCT ID NCT03318445
Title Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pamela Munster
Indications

Advanced Solid Tumor

Therapies

Rucaparib

Irinotecan + Rucaparib

Age Groups: adult senior

Additional content available in CKB BOOST